DE3881458D1 - Verfahren zur herstellung von makrolid-derivaten. - Google Patents

Verfahren zur herstellung von makrolid-derivaten.

Info

Publication number
DE3881458D1
DE3881458D1 DE8888308345T DE3881458T DE3881458D1 DE 3881458 D1 DE3881458 D1 DE 3881458D1 DE 8888308345 T DE8888308345 T DE 8888308345T DE 3881458 T DE3881458 T DE 3881458T DE 3881458 D1 DE3881458 D1 DE 3881458D1
Authority
DE
Germany
Prior art keywords
group
macrolide derivatives
chem
compound
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888308345T
Other languages
English (en)
Other versions
DE3881458T2 (de
Inventor
Michael V J Ramsay
Stephen Freeman
Anthony H Shingler
Oswy Z Pereira
Simon C Dolan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE3881458D1 publication Critical patent/DE3881458D1/de
Application granted granted Critical
Publication of DE3881458T2 publication Critical patent/DE3881458T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE88308345T 1987-09-11 1988-09-09 Verfahren zur Herstellung von Makrolid-Derivaten. Expired - Fee Related DE3881458T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878721373A GB8721373D0 (en) 1987-09-11 1987-09-11 Chemical process

Publications (2)

Publication Number Publication Date
DE3881458D1 true DE3881458D1 (de) 1993-07-08
DE3881458T2 DE3881458T2 (de) 1993-10-14

Family

ID=10623610

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88308345T Expired - Fee Related DE3881458T2 (de) 1987-09-11 1988-09-09 Verfahren zur Herstellung von Makrolid-Derivaten.

Country Status (17)

Country Link
EP (1) EP0307221B1 (de)
JP (1) JPH01163182A (de)
KR (1) KR890005116A (de)
AT (1) ATE90101T1 (de)
AU (1) AU621063B2 (de)
BR (1) BR8804664A (de)
CA (1) CA1333600C (de)
DD (1) DD274421A5 (de)
DE (1) DE3881458T2 (de)
DK (1) DK168524B1 (de)
ES (1) ES2040863T3 (de)
GB (1) GB8721373D0 (de)
HU (2) HU207085B (de)
IE (1) IE62759B1 (de)
NZ (1) NZ226118A (de)
PT (1) PT88468B (de)
ZA (1) ZA886739B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4429209A (en) * 1981-10-19 1984-01-31 Duro Dyne Corporation Resistance welding pin
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
EP0262384B1 (de) * 1986-09-12 1992-11-04 American Cyanamid Company 23-Deoxy-Derivate von LL-F28249-Verbindungen
US4806527A (en) * 1987-03-16 1989-02-21 Merck & Co., Inc. Avermectin derivatives

Also Published As

Publication number Publication date
IE882745L (en) 1989-03-11
AU621063B2 (en) 1992-03-05
HU207085B (en) 1993-03-01
HU203353B (en) 1991-07-29
EP0307221B1 (de) 1993-06-02
DD274421A5 (de) 1989-12-20
ZA886739B (en) 1989-08-30
GB8721373D0 (en) 1987-10-21
DK504788D0 (da) 1988-09-09
AU2208988A (en) 1989-03-16
JPH01163182A (ja) 1989-06-27
BR8804664A (pt) 1989-04-18
ES2040863T3 (es) 1993-11-01
HUT48258A (en) 1989-05-29
EP0307221A2 (de) 1989-03-15
NZ226118A (en) 1989-12-21
PT88468A (pt) 1988-10-01
ATE90101T1 (de) 1993-06-15
KR890005116A (ko) 1989-05-11
DK168524B1 (da) 1994-04-11
HU903199D0 (en) 1990-10-28
DK504788A (da) 1989-03-12
CA1333600C (en) 1994-12-20
DE3881458T2 (de) 1993-10-14
IE62759B1 (en) 1995-02-22
EP0307221A3 (en) 1989-10-25
PT88468B (pt) 1992-11-30

Similar Documents

Publication Publication Date Title
ATE229960T1 (de) Verfahren zur herstellung von 13-ether-derivaten von milbemycinen und zwischenprodukte
DE68906705D1 (de) Verfahren zur herstellung von baccatin-iii-derivaten und von desacetyl-10-baccatin-iii.
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
DE58909125D1 (de) Verfahren zur Herstellung von Diorganodialkoxysilanen.
ATE207055T1 (de) Verfahren zur herstellung von 4-aryl-3- hydroxymethyl-piperidinen
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
ATE191461T1 (de) Verfahren zur herstellung von alkoxyimino acetamid-derivaten
ATE115567T1 (de) Verfahren zur herstellung von halogensulfonyl- substituierten pyridinen.
DE3881458D1 (de) Verfahren zur herstellung von makrolid-derivaten.
ATE138376T1 (de) Verfahren zur herstellung von benzylphthalazinonderivaten und von deren salzen
ATE402940T1 (de) Verfahren zur herstellung von 3-cephem- verbindungen
DE69839732D1 (de) Verfahren zur herstellung von 3,4-dihydroxy-3cyclobuten-1,2-dion
DE3677830D1 (de) Verfahren zur herstellung von rooperol, hypoxosid und deren derivaten.
ATE189887T1 (de) Vitamin-d-derivat und verfahren zu seiner herstellung
ATE223377T1 (de) Verfahren zur herstellung von difluoracetophenon- derivaten
ATE299498T1 (de) Verfahren zur herstellung von imidazolderivaten
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
DE69520554D1 (de) Verfahren zur herstellung von indolocarbazol-derivaten
DE69101790D1 (de) Verfahren zur Herstellung von Vitamin A Aldehyd.
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
ATE206109T1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
DE59502722D1 (de) Verfahren und Zwischenprodukte zur Herstellung von 5-Oxaspiro [2.4] heptan-6-on
DE3772703D1 (de) Verfahren zur herstellung von penemen.
ATE208388T1 (de) Eintopfverfahren zur herstellung von 2- oxazolidinonderivate
ATE88474T1 (de) Verfahren zur herstellung eines makrolidderivates.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee